HALOZYME THERAPEUTICS INC (HALO) Stock Price & Overview
NASDAQ:HALO • US40637H1095
Current stock price
The current stock price of HALO is 62.13 USD. Today HALO is up by 0.81%. In the past month the price decreased by -11.05%. In the past year, price increased by 3.95%.
HALO Key Statistics
- Market Cap
- 7.333B
- P/E
- 15.04
- Fwd P/E
- 7.60
- EPS (TTM)
- 4.13
- Dividend Yield
- N/A
HALO Stock Performance
HALO Stock Chart
HALO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to HALO. When comparing the yearly performance of all stocks, HALO is a bad performer in the overall market: 70.9% of all stocks are doing better.
HALO Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to HALO. HALO scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
HALO Earnings
On February 17, 2026 HALO reported an EPS of -0.24 and a revenue of 451.77M. The company missed EPS expectations (-110.7% surprise) and beat revenue expectations (1.13% surprise).
HALO Forecast & Estimates
15 analysts have analysed HALO and the average price target is 86.19 USD. This implies a price increase of 38.73% is expected in the next year compared to the current price of 62.13.
For the next year, analysts expect an EPS growth of 97.97% and a revenue growth 26.75% for HALO
HALO Groups
Sector & Classification
HALO Financial Highlights
Over the last trailing twelve months HALO reported a non-GAAP Earnings per Share(EPS) of 4.13. The EPS decreased by -2.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 22.69% | ||
| ROA | 12.55% | ||
| ROE | 649.18% | ||
| Debt/Equity | 43.89 |
HALO Ownership
HALO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.36 | 370.255B | ||
| AMGN | AMGEN INC | 15.29 | 188.011B | ||
| GILD | GILEAD SCIENCES INC | 15.42 | 166.661B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.86 | 110.013B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.03 | 77.991B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.36 | 42.088B | ||
| INSM | INSMED INC | N/A | 31.319B | ||
| BIIB | BIOGEN INC | 11.67 | 26.98B | ||
| NTRA | NATERA INC | N/A | 25.887B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.7 | 22.916B | ||
| MRNA | MODERNA INC | N/A | 19.573B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.333B | ||
| INCY | INCYTE CORP | 11.79 | 17.971B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About HALO
Company Profile
The company is headquartered in San Diego, California and currently employs 423 full-time employees. The company went IPO on 2003-01-30.
Company Info
IPO: 2003-01-30
HALOZYME THERAPEUTICS INC
12390 El Camino Real
San Diego CALIFORNIA 92121-1345 US
CEO: Helen I. Torley
Employees: 423
Phone: 13026587581
HALOZYME THERAPEUTICS INC / HALO FAQ
Can you describe the business of HALOZYME THERAPEUTICS INC?
The company is headquartered in San Diego, California and currently employs 423 full-time employees. The company went IPO on 2003-01-30.
Can you provide the latest stock price for HALOZYME THERAPEUTICS INC?
The current stock price of HALO is 62.13 USD. The price increased by 0.81% in the last trading session.
What is the dividend status of HALOZYME THERAPEUTICS INC?
HALO does not pay a dividend.
What is the ChartMill technical and fundamental rating of HALO stock?
HALO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
On which exchange is HALO stock listed?
HALO stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for HALO stock?
The PE ratio for HALOZYME THERAPEUTICS INC (HALO) is 15.04. This is based on the reported non-GAAP earnings per share of 4.13 and the current share price of 62.13 USD.
Is HALOZYME THERAPEUTICS INC (HALO) expected to grow?
The Revenue of HALOZYME THERAPEUTICS INC (HALO) is expected to grow by 26.75% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.